GT
PAVM icon

Glenmede Trust’s PAVmed PAVM Stock Holding History

Glenmede Trust’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33
Closed -$4.42K – 1331
2023
Q3 		$4.42K Hold
33
– – ﹤0.01% 1245
2023
Q2 		$5.6K Hold
33
– – ﹤0.01% 1265
2023
Q1 		$5.6K Hold
33
– – ﹤0.01% 1272
2022
Q4 		$7.2K Hold
33
– – ﹤0.01% 1261
2022
Q3 		$12K Hold
33
– – ﹤0.01% 1237
2022
Q2 		$14K Buy
+33
New +$15.9K ﹤0.01% 1245

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Glenmede Trust's PAVM Position: Q4 2023 in Review

Glenmede Trust sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 33 shares — an estimated $4.42K sold.

Glenmede Trust first reported a position in PAVM in Q2 2022 and held it in 6 quarters. The position peaked at $14K in Q2 2022. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Glenmede Trust reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Glenmede Trust sold 33 PAVmed shares in Q4 2023, an estimated $4.42K.
  • Glenmede Trust first reported a position in PAVmed in Q2 2022 and held it in 6 quarters.
  • Glenmede Trust's PAVmed position peaked at $14K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Glenmede Trust's 13F filing for Q4 2023, filed 13 Feb 2024.